Phenotype at diagnosis predicts recurrence rates in Crohn's disease
- PMID: 16361306
- PMCID: PMC1856253
- DOI: 10.1136/gut.2005.084061
Phenotype at diagnosis predicts recurrence rates in Crohn's disease
Abstract
Background: In Crohn's disease (CD), studies associating phenotype at diagnosis and subsequent disease activity are important for patient counselling and health care planning.
Aims: To calculate disease recurrence rates and to correlate these with phenotypic traits at diagnosis.
Methods: A prospectively assembled uniformly diagnosed European population based inception cohort of CD patients was classified according to the Vienna classification for disease phenotype at diagnosis. Surgical and non-surgical recurrence rates throughout a 10 year follow up period were calculated. Multivariate analysis was performed to classify risk factors present at diagnosis for recurrent disease.
Results: A total of 358 were classified for phenotype at diagnosis, of whom 262 (73.2%) had a first recurrence and 113 patients (31.6%) a first surgical recurrence during the first 10 years after diagnosis. Patients with upper gastrointestinal disease at diagnosis had an excess risk of recurrence (hazard ratio 1.54 (95% confidence interval (CI) 1.13-2.10)) whereas age >/=40 years at diagnosis was protective (hazard ratio 0.82 (95% CI 0.70-0.97)). Colonic disease was a protective characteristic for resective surgery (hazard ratio 0.38 (95% CI 0.21-0.69)). More frequent resective surgical recurrences were reported from Copenhagen (hazard ratio 3.23 (95% CI 1.32-7.89)).
Conclusions: A mild course of disease in terms of disease recurrence was observed in this European cohort. Phenotype at diagnosis had predictive value for disease recurrence with upper gastrointestinal disease being the most important positive predictor. A phenotypic North-South gradient in CD may be present, illustrated by higher surgery risks in some of the Northern European centres.
Conflict of interest statement
Conflict of interest: None declared.
Comment in
-
Recurrence rates in Crohn's disease: predicting the future and predicting the past.Gut. 2006 Aug;55(8):1069-70. doi: 10.1136/gut.2005.088658. Gut. 2006. PMID: 16849342 Free PMC article. Review.
Similar articles
-
Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.Am J Gastroenterol. 2009 Feb;104(2):371-83. doi: 10.1038/ajg.2008.38. Epub 2009 Jan 27. Am J Gastroenterol. 2009. PMID: 19174787
-
Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.Dan Med J. 2014 Jan;61(1):B4778. Dan Med J. 2014. PMID: 24393595
-
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort.Gut. 2006 Apr;55(4):510-8. doi: 10.1136/gut.2005.072793. Epub 2005 Sep 8. Gut. 2006. PMID: 16150857 Free PMC article.
-
Clinical predictors of Crohn's disease course.Eur J Gastroenterol Hepatol. 2016 Oct;28(10):1122-5. doi: 10.1097/MEG.0000000000000698. Eur J Gastroenterol Hepatol. 2016. PMID: 27391171 Review.
-
[Different approaches for medical or surgical management of Crohn's disease: the importance of the classification of Vienna].Ann Ital Chir. 2006 Nov-Dec;77(6):485-96. Ann Ital Chir. 2006. PMID: 17343232 Review. Italian.
Cited by
-
Development of a Novel Metagenomic Biomarker for Prediction of Upper Gastrointestinal Tract Involvement in Patients With Crohn's Disease.Front Microbiol. 2020 Jun 3;11:1162. doi: 10.3389/fmicb.2020.01162. eCollection 2020. Front Microbiol. 2020. PMID: 32582102 Free PMC article.
-
Natural history and complications of IBD.Curr Gastroenterol Rep. 2009 Dec;11(6):481-7. doi: 10.1007/s11894-009-0073-8. Curr Gastroenterol Rep. 2009. PMID: 19903424 Review.
-
Inflammatory bowel disease course in Crohn's disease: is the natural history changing?World J Gastroenterol. 2014 Mar 28;20(12):3198-207. doi: 10.3748/wjg.v20.i12.3198. World J Gastroenterol. 2014. PMID: 24696605 Free PMC article. Review.
-
Factors associated with the achievement of mucosal healing in Crohn's disease: the benefit of endoscopic monitoring in treating to target.Therap Adv Gastroenterol. 2017 Jun;10(6):453-463. doi: 10.1177/1756283X17698089. Epub 2017 Mar 28. Therap Adv Gastroenterol. 2017. PMID: 28567115 Free PMC article.
-
Extended versus limited mesenteric excision in bowel resection for Crohn's disease: a meta-analysis and systematic review.Tech Coloproctol. 2025 Mar 9;29(1):80. doi: 10.1007/s10151-024-03108-w. Tech Coloproctol. 2025. PMID: 40057916 Free PMC article.
References
-
- Greenstein R J, Collins M T. Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic? Lancet 2004364396–397. - PubMed
-
- Podolsky D K. Inflammatory bowel disease. N Engl J Med 2002347417–429. - PubMed
-
- Hellers G. Crohn's disease in Stockholm county 1955–1974. A study of epidemiology, results of surgical treatment and long‐term prognosis. Acta Chirurg Scand Suppl 19794901–84. - PubMed
-
- Wolters F L, Russel M G, Stockbrugger R W. Systematic review: has disease outcome in Crohn's disease changed during the last four decades? Aliment Pharmacol Ther 200420483–496. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical